Bentyl (Dicyclomine) for Chronic Diarrhea
Bentyl (dicyclomine) is moderately effective for treating chronic diarrhea, particularly in patients with irritable bowel syndrome (IBS), but is not considered first-line therapy for chronic diarrhea in general. It works primarily as an antispasmodic with anticholinergic properties that can help reduce abdominal pain and improve bowel habits.
Efficacy for Chronic Diarrhea
Evidence Base
- Dicyclomine has demonstrated efficacy for IBS symptoms in controlled clinical trials, with 82% of patients showing favorable clinical response compared to 55% with placebo when given at doses of 160 mg daily (40 mg four times daily) 1
- Dicyclomine is FDA-approved specifically for functional bowel/irritable bowel syndrome 1
- The British Society of Gastroenterology guidelines indicate that anticholinergic antispasmodics like dicyclomine bromide show significant improvement in pain for IBS patients, though dry mouth is a common side effect 2
Treatment Algorithm for Chronic Diarrhea
First-line treatments (preferred over dicyclomine):
Second-line treatments:
Third-line treatments:
Proper Use of Dicyclomine
- Dosing: 40 mg four times daily (160 mg total daily dose) 1, 5
- Duration: Initial trial of 2 weeks to assess efficacy 5
- Target symptoms: Most effective for abdominal pain, tenderness, and improving bowel habits 5
Limitations and Side Effects
- Dicyclomine primarily targets abdominal pain rather than diarrhea itself 6
- Common side effects include dry mouth, visual disturbance, and dizziness due to anticholinergic properties 2
- Less effective than loperamide or codeine phosphate for controlling chronic diarrhea specifically 3
Special Considerations
- For cancer patients with chronic diarrhea, anticholinergic antispasmodics like dicyclomine may be used to alleviate bowel cramping, but are not first-line therapy 2
- For patients with bile salt malabsorption (approximately 10% of diarrhea-predominant IBS patients), cholestyramine would be more appropriate 2
- In patients with radiation-induced diarrhea, antidiarrheal agents like loperamide are preferred first-line treatments 2
Conclusion
While dicyclomine can help manage chronic diarrhea, particularly in IBS patients, it works primarily by reducing abdominal pain and spasms rather than directly controlling diarrhea. For patients whose primary symptom is diarrhea without significant pain, loperamide would be a more effective first-line treatment. Dicyclomine should be considered when abdominal pain and spasms are prominent features accompanying chronic diarrhea.